Gene silencing using multifunctionalized gold nanoparticles for cancer therapy

Methods in Molecular Biology

Volumn 1530, Issue , 2017, Pages 319-336

  Fernandes, Alexandra R ^a   Baptista, Pedro V ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Au nanobeacon; Colorectal carcinoma cell lines; Gene silencing; Gold nanoparticles; KRAS; Peptides; Targeted delivery

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; COMPLEMENTARY DNA; FLUORESCENT DYE; GOLD NANOPARTICLE; K RAS PROTEIN; MESSENGER RNA; OLIGONUCLEOTIDE; PEPTIDE; ANTISENSE OLIGONUCLEOTIDE; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE; PROTEIN P21; TUMOR MARKER;

CANCER CELL; CANCER GENE THERAPY; CELL INTERACTION; CELL TRANSPORT; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DNA HAIRPIN; FIBROBLAST; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HCT 116 CELL LINE; HUMAN; HUMAN CELL; HYBRIDIZATION; IN VITRO STUDY; MOLECULAR RECOGNITION; TUMOR CELL; CELL SURVIVAL; CHEMISTRY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE TRANSFER; GENETICS; NEOPLASM; TUMOR CELL LINE;

BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL SURVIVAL; FLOW CYTOMETRY; GENE SILENCING; GENE TARGETING; GENE TRANSFER TECHNIQUES; GOLD; HUMANS; METAL NANOPARTICLES; MICROSCOPY, FLUORESCENCE; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; POLYETHYLENE GLYCOLS; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 85011617188     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6646-2_19     Document Type: Chapter

References (26)

1. Baptista PV (2014) Gold nanobeacons: a potential nanotheranostics platform. Nanomedicine (Lond) 9:2247-2250
2. Cabral RM, Baptista PV (2014) Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles. Expert Rev Mol Diagn 14:1041-1052
3. Baptista PV (2014) Nanodiagnostics: leaving the research lab to enter the clinics? Diagnosis 1:305-309
4. Gil PR, Parak WJ (2008) Composite nanoparticles take aim at cancer. ACS Nano 2:2200e5
5. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751e60
6. Conde J, Rosa J, de la Fuente JM, Baptista PV (2013) Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. Biomaterials 34:2516-2523
7. Conde J, Ambrosone A, Sanz V, Hernandez Y, Marchesano V, Tian F, Child H, Berry CC, Ibarra MR, Baptista PV, Tortiglione C, de la Fuente JM (2012) Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano 6:8316-8324
8. Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60:1307e15
9. Conde J, Doria G, Baptista P (2012) Noble metal nanoparticles applications in cancer. J Drug Deliv 2012:751075
10. Conde J, Larguinho M, Cordeiro A et al (2014) Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis. Nanotoxicology 8:521-532
11. Modarresi F, Faghihi MA, Lopez-Toledano MA, Fatemi RP, Magistri M, Brothers SP, van der Brug MP, Wahlestedt C (2012) Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol 30:453-459
12. Fichou Y, Ferec C (2006) The potential of oligonucleotides for therapeutic applications. Trends Biotechnol 24:563-570
13. Moreno PMD, Pêgo AP (2014) Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Front Chem 2:87
14. Rosa J, Conde J, de la Fuente JM, Lima JC, Baptista PV (2012) Gold-nanobeacons for real-time monitoring of RNA synthesis. Biosens Bioelectron 36:161-167
15. Jančík S, Drábek J, Radzioch D, Hajdúch M (2010) Clinical relevance of KRAS in human cancers. J Biomed Biotechnol 2010:150960
16. Kranenburg O (2005) The KRAS oncogene: past, present, and future. Biochim Biophys Acta 1756:81-82
17. Brito H, Martins AC, Lavrado J, Mendes E, Francisco AP, Santos SA et al (2015) Targeting KRAS oncogene in colon cancer cells with 7-Carboxylate indolo[3,2-b]quinoline trialkylamine derivatives. PLoS One 10:e0126891
18. Wang JH, Newbury LJ, Knisely AS, Monia B, Hendry BM, Sharpe CC (2012) Antisense knockdown of Kras inhibits fibrosis in a rat model of unilateral ureteric obstruction. Am J Pathol 180:82-90
19. Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J (2012) Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci 13:12153-12168
20. Luís DV, Silva J, Tomaz AI, de Almeida RFM, Larguinho M, Baptista PV, Martins LMDRS, Silva TFS, Borralho PM, Rodrigues CMP, Rodrigues AS, Pombeiro AJL, Fernandes AR (2014) Insights into themechanisms underlying the anti-proliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies. J Biol Inorg Chem 19:787-803
21. Lee PC, Meisel D (1982) Adsorption and surface-enhanced Raman of dyes on silver and gold sols. J Phys Chem 86:3391-3395
22. Sanz V, Conde J, Hernández Y, Baptista PV, Ibarra MR, de la Fuente JM (2012) Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles. J Nanoparticles Res 14:917 (9 pages)
23. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
24. Silva TFS, Martins LMDRS, Guedes da Silva MF, Fernandes AR, Silva A, Borralho PM, Santos S, Rodrigues CMP, Pombeiro AJL (2012) Cobalt complexes bearing scorpionate or pyrazole ligands: synthesis, characterization and applications as in vitro tumour-inhibitors. Dalton Trans 41:12888-12897
25. Sperling RA, Parak WJ (2010) Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans A Math Phys Eng Sci 368:1333-1383
26. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254